Trial Profile
Phase II Study of Z-206
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2016
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Kyowa Hakko Kirin; Zeria
- 09 Jun 2016 New trial record